<DOC>
	<DOC>NCT00753116</DOC>
	<brief_summary>The purpose of this this study is to investigate the clinical utility of renal denervation in the treatment of ESRD patients with refractory hypertension.</brief_summary>
	<brief_title>Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure, Chronic</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Systolic blood pressure of 160 mmHg or greater On 3 or more antihypertensive medications On dialysis for more than 6 months Renal artery abnormalities Known secondary hypertension attributable to a cause other than sleep apnea MI, angina, CVA within 6 months Others</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>